Position in AZN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$15,218,142
-$1,569,224 QoQ
Shares Held
80,256
-5.7% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#261
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OSSIAM holds $190,268,884 across 10 Drug Manufacturers - General names. AZN ranks #2 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
90,300 | $108,308,538 | |
| 2 | AZN |
Astrazeneca PLC
This page
|
80,256 | $15,218,142 | |
| 3 | AMGN |
Amgen Inc
|
36,294 | $13,142,783 | |
| 4 | ABBV |
AbbVie Inc.
|
50,502 | $12,708,323 | |
| 5 | MRK |
Merck & Co., Inc.
|
91,787 | $11,794,629 | |
| 6 | BIIB |
Biogen Inc.
|
39,223 | $8,474,521 | |
| 7 | PFE |
Pfizer Inc
|
275,753 | $6,640,132 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
49,573 | $6,263,052 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,218,142 | 80,256 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $16,787,366 | 85,120 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||